Back to Search
Start Over
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
- Source :
- The Lancet. Infectious Diseases, The Lancet Infectious Diseases, Vol. 21, No 5 (2021) pp. 600-601, The Lancet Infectious Diseases
- Publication Year :
- 2021
- Publisher :
- Elsevier Ltd., 2021.
- Subjects :
- Adult
Male
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
Adolescent
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
SARS-CoV-2/immunology
COVID-19 Serological Testing
Young Adult
Seroepidemiologic Studies
Pandemic
Correspondence
Seroprevalence
Medicine
Humans
Child
ddc:613
Aged
ddc:616
Aged, 80 and over
ddc:618
biology
business.industry
SARS-CoV-2
Infant, Newborn
COVID-19
Infant
Middle Aged
Virology
Infectious Diseases
Child, Preschool
biology.protein
COVID-19/diagnosis/epidemiology
Female
Antibody
business
Subjects
Details
- Language :
- English
- ISSN :
- 14744457 and 14733099
- Volume :
- 21
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- The Lancet. Infectious Diseases
- Accession number :
- edsair.doi.dedup.....edb2b08b003a523bc4bc136787d4451b